Cardiovascular and Lifestyle Risk Factors and Cognitive Function in Patients With Stable Coronary Heart Disease.
Aged
Benzaldehydes
/ therapeutic use
Cardiovascular Diseases
/ etiology
Cognition
/ physiology
Cognitive Dysfunction
/ psychology
Coronary Disease
/ drug therapy
Exercise
/ physiology
Female
Humans
Male
Middle Aged
Oximes
/ therapeutic use
Phospholipase A2 Inhibitors
/ therapeutic use
Risk Factors
Stroke
/ etiology
Montreal Cognitive Assessment
cognitive impairment
coronary heart disease
risk factor
Journal
Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524
Informations de publication
Date de publication:
02 04 2019
02 04 2019
Historique:
entrez:
23
3
2019
pubmed:
23
3
2019
medline:
21
7
2020
Statut:
ppublish
Résumé
Background Vascular risk factors have been associated with differences in cognitive performance in epidemiological studies, but evidence in patients with coronary heart disease is more limited. Methods and Results The Montreal Cognitive Assessment score obtained 3.2±0.37 years after randomization to darapladib, a reversible inhibitor of lipoprotein phospholipase A
Identifiants
pubmed: 30897999
doi: 10.1161/JAHA.118.010641
pmc: PMC6509727
doi:
Substances chimiques
Benzaldehydes
0
Oximes
0
Phospholipase A2 Inhibitors
0
darapladib
UI1U1MYH09
Banques de données
ClinicalTrials.gov
['NCT00799903']
Types de publication
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e010641Références
Lancet. 2006 Apr 15;367(9518):1262-70
pubmed: 16631882
Stroke. 2017 Oct;48(10):e284-e303
pubmed: 28883125
J Gerontol A Biol Sci Med Sci. 2013 Apr;68(4):433-40
pubmed: 22982688
Circulation. 2014 Apr 15;129(15):1560-7
pubmed: 24687777
Neurology. 2013 Jun 4;80(23):2112-20
pubmed: 23658380
Eur Heart J. 2013 Nov;34(42):3286-93
pubmed: 24014220
Cochrane Database Syst Rev. 2015 Oct 29;(10):CD010775
pubmed: 26513331
Sci Rep. 2016 Sep 09;6:33073
pubmed: 27609335
N Engl J Med. 2010 Apr 1;362(13):1173-80
pubmed: 20357280
Neurology. 2011 Aug 2;77(5):461-8
pubmed: 21810696
Neurology. 2011 Sep 27;77(13):1272-5
pubmed: 21917776
N Engl J Med. 2014 May 1;370(18):1702-11
pubmed: 24678955
J Am Heart Assoc. 2019 Apr 2;8(7):e010641
pubmed: 30897999
Atherosclerosis. 2014 Aug;235(2):384-91
pubmed: 24929287
JAMA Psychiatry. 2017 Jan 01;74(1):58-67
pubmed: 27893026
Sci Rep. 2017 Sep 26;7(1):12311
pubmed: 28951620
J Am Heart Assoc. 2016 Jun 21;5(6):
pubmed: 27329448
Alzheimers Dement. 2018 Nov;14(11):1450-1459
pubmed: 29605221
PLoS One. 2012;7(6):e38268
pubmed: 22675535
Ann Neurol. 2006 Jan;59(1):139-44
pubmed: 16278861
Lancet. 2017 Dec 16;390(10113):2673-2734
pubmed: 28735855
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
Eur Heart J. 2016 Jul 01;37(25):1993-2001
pubmed: 27109584
Ann Intern Med. 2010 Aug 3;153(3):182-93
pubmed: 20547887
Alzheimers Dement (Amst). 2015 Sep 21;1(4):464-71
pubmed: 27239525
Nutr Rev. 2009 Feb;67(2):114-20
pubmed: 19178654
Arch Neurol. 2007 Mar;64(3):416-20
pubmed: 17353386
Lancet. 2005 Dec 17;366(9503):2112-7
pubmed: 16360788